-
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Given Average Recommendation of "Moderate Buy" by Brokerages
Source: Buzz FX / 26 Nov 2024 02:36:10 America/New_York
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Given Average Recommendation of "Moderate Buy" by Brokerages Written by MarketBeat November 26, 2024 Share Link copied to clipboard. Shares of Neurocrine Biosciences, Inc.
Read more...